Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 21091 AL 21105

Anti-HMGB1 monoclonal antibody therapy for a wide range of CNS and PNS diseases

Nishibori M, Mori S, Takahashi HK.

J Pharmacol Sci. 2019 May;140(1):94-101. doi: 10.1016/j.jphs.2019.04.006. Epub 2019 May 4.

Mammalian cystatin and protagonists in brain diseases

Amin F, Khan MS, Bano B.

J Biomol Struct Dyn. 2020 Apr;38(7):2171-2196. doi: 10.1080/07391102.2019.1620636. Epub 2019 Jun 5.

α-synuclein in the pathophysiology of Alzheimer's disease

Twohig D, Nielsen HM.

Mol Neurodegener. 2019 Jun 11;14(1):23. doi: 10.1186/s13024-019-0320-x.

Gene-by-environment interactions in Alzheimer's disease and Parkinson's disease

Dunn AR, O'Connell KMS, Kaczorowski CC.

Neurosci Biobehav Rev. 2019 Aug;103:73-80. doi: 10.1016/j.neubiorev.2019.06.018. Epub 2019 Jun 14.

Oxidative Stress in Neurodegenerative Diseases: From a Mitochondrial Point of View

Cenini G, Lloret A, Cascella R.

Oxid Med Cell Longev. 2019 May 9;2019:2105607. doi: 10.1155/2019/2105607. eCollection 2019.

miRNAs Identify Shared Pathways in Alzheimer's and Parkinson's Diseases

Sadlon A, Takousis P, Alexopoulos P, Evangelou E, Prokopenko I, Perneczky R.

Trends Mol Med. 2019 Aug;25(8):662-672. doi: 10.1016/j.molmed.2019.05.006. Epub 2019 Jun 17.

Mangiferin: A multipotent natural product preventing neurodegeneration in Alzheimer's and Parkinson's disease models

Feng ST, Wang ZZ, Yuan YH, Sun HM, Chen NH, Zhang Y.

Pharmacol Res. 2019 Aug;146:104336. doi: 10.1016/j.phrs.2019.104336. Epub 2019 Jul 2.

Neural regeneration therapies for Alzheimer's and Parkinson's disease-related disorders

Reddy AP, Ravichandran J, Carkaci-Salli N.

Biochim Biophys Acta Mol Basis Dis. 2020 Apr 1;1866(4):165506. doi: 10.1016/j.bbadis.2019.06.020. Epub 2019 Jul 2.

Lessons on Differential Neuronal-Death-Vulnerability from Familial Cases of Parkinson's and Alzheimer's Diseases

Franco R, Navarro G, Martínez-Pinilla E.

Int J Mol Sci. 2019 Jul 4;20(13):3297. doi: 10.3390/ijms20133297.

Potential Benefits of Nobiletin, A Citrus Flavonoid, against Alzheimer's Disease and Parkinson's Disease

Nakajima A, Ohizumi Y.

Int J Mol Sci. 2019 Jul 10;20(14):3380. doi: 10.3390/ijms20143380.

Combustion and friction-derived nanoparticles and industrial-sourced nanoparticles: The culprit of Alzheimer and Parkinson's diseases

Calderón-Garcidueñas L, Reynoso-Robles R, González-Maciel A.

Environ Res. 2019 Sep;176:108574. doi: 10.1016/j.envres.2019.108574. Epub 2019 Jul 5.

Emerging roles for high-density lipoproteins in neurodegenerative disorders

Bahrami A, Barreto GE, Lombardi G, Pirro M, Sahebkar A.

Biofactors. 2019 Sep;45(5):725-739. doi: 10.1002/biof.1541. Epub 2019 Jul 13.

Dopa Responsive Parkinsonism in an Early Onset Alzheimer's Disease Patient with a Presenilin 1 Mutation (A434T)

Jo H, Kim M, Park S, Park JE, Cho SH, Kim SJ, Jang H, Jung YH, Kim J, Na DL, Seo SW, Cho JW, Kim HJ.

J Alzheimers Dis. 2019;71(1):7-13. doi: 10.3233/JAD-190469.

Standardized measurement of circulating vitamin D [25(OH)D] and its putative role as a serum biomarker in Alzheimer's disease and Parkinson's disease

Bivona G, Lo Sasso B, Iacolino G, Gambino CM, Scazzone C, Agnello L, Ciaccio M.

Clin Chim Acta. 2019 Oct;497:82-87. doi: 10.1016/j.cca.2019.07.022. Epub 2019 Jul 19.

Role of the gut microbiota in the development of various neurological diseases

Castillo-Álvarez F, Marzo-Sola ME.

Neurologia (Engl Ed). 2022 Jul-Aug;37(6):492-498. doi: 10.1016/j.nrl.2019.03.017. Epub 2019 Jul 21.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias